Myeloproliferative disorders originate in the clonal expansion of a transformed pluripotential hematopoietic progenitor cell. This results in a group of syndromes that include polycythemia vera, essential thrombocythemia,
Harriet S. Gilbert, MD
Advertisement
Articles by Harriet S. Gilbert, MD
Advertisement
Latest Updated Articles
- Diagnosis and Treatment of Thrombocythemia in Myeloproliferative Disorders
Published: August 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Could Scorpion Venom Component Play a Role in Glioblastoma Management?
2
Evaluating the Viability of Antibody Drug Conjugates for Glioblastoma
3
FDA Approves Abbreviated NDA for Dasatinib Tablets in Leukemia Indications
4
What Were The Most Impactful GU Oncology Data From ESMO 2025?
5
